BI
birdflustocks
Community Contributor
Member since 2025
Views1.6kTotal number of views
Followers34Total number of followers
Comments0Total number of comments
No bio added yet
No link added
Cidara Therapeutics: The underestimated potential of CD388
Summary CD388 is a universal long-lasting influenza drug against all seasonal and pandemic influenza viruses in a phase 2b clinical trial. CD388 is not a vaccine but would provide 6 months of protection.Read more
1.6k
users have viewed this narrative9users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
BI
US$100
121.4% overvalued intrinsic discount
birdflustocks's Fair Value
Revenue
83.73% p.a.
Profit Margin
19.58%
Future PE
26.11x
Price in 2035
US$7.22k